:: Volume 10, Issue 4 (12-2024) ::
IBBJ 2024, 10(4): 0-0 Back to browse issues page
Benzimidazole Derivatives as Multitarget Agents: Synthesis, Characterization, Invitro Alpha-glucosidase Inhibition and Antioxidants Activity
Ibrahim Gidado *1 , Abdullahi Yunusa Idris2 , Asmau Nasir Hamza2 , Aliyu Musa2 , Maryam Abdullahi2 , Ahmadu Jibril2 , Lukman Hassan Ali2 , Jimoh Yusuf2
1- Federal College of Education, Yola & Ahmadu Bello University, Zaria , ibrahimgidado74@gmail.com
2- Ahmadu Bello University, Zaria
Abstract:   (2854 Views)
Nitrogen-containing compounds, specifically benzimidazole derivatives, represent a significant class of molecules with diverse biological properties that have garnered considerable attention in medicinal chemistry. In this study, two 2-substituted benzimidazoles were successfully synthesized using a boric acid-catalyzed method. The resulting products demonstrated good yields and sharp melting points. The structures of the synthesized compounds were elucidated using Fourier-transform infrared (FT-IR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy, including both proton (¹H-NMR) and carbon (¹³C-NMR) analyses.The compounds were evaluated for their alpha-glucosidase inhibitory activity and antioxidant properties. Both compounds exhibited notable antidiabetic and antioxidant activities. Notably, the compound designated as BL24 demonstrated the highest alpha-glucosidase inhibitory activity and radical scavenging properties. These experimental results indicate that benzimidazoles possess effective antidiabetic and antioxidant potential.
Keywords: Benzimidazole, Antioxidant, Alpha-Glucosidase, Oxidative Stress, Diabetes Mellitus
Full-Text [PDF 749 kb]   (1095 Downloads)    
Type of Study: Original Article | Subject: Other
Received: 2024/09/29 | Accepted: 2024/11/23 | Published: 2024/12/29


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 4 (12-2024) Back to browse issues page